Zhejiang Anglikang Pharmaceutical Co Ltd Class A (002940) — Financial Flexibility Index
Zhejiang Anglikang Pharmaceutical Co Ltd Class A (002940) has a Financial Flexibility Index of 0.12x as of September 2025. Free cash flow of CN¥129.23 Million (operating CF CN¥112.57 Million minus capex CN¥16.66 Million) represents 0% of total liabilities (CN¥1.10 Billion). Check Zhejiang Anglikang Pharmaceutical Co Ltd strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Zhejiang Anglikang Pharmaceutical Co Ltd Class A Financial Flexibility Index (2014–2025)
Historical Financial Flexibility Index trend for Zhejiang Anglikang Pharmaceutical Co Ltd Class A across 12 annual periods. See Zhejiang Anglikang Pharmaceutical Co Ltd (002940) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Zhejiang Anglikang Pharmaceutical Co Ltd Class A (2014–2025)
Year-by-year free cash flow to debt coverage for Zhejiang Anglikang Pharmaceutical Co Ltd Class A. For the full company profile including market capitalisation, see Zhejiang Anglikang Pharmaceutical Co Ltd market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.27x | CN¥294.08 Million | CN¥244.13 Million | CN¥1.08 Billion | ▼ -8.3% |
| 2024 | 0.30x | CN¥348.06 Million | CN¥253.60 Million | CN¥1.18 Billion | ▼ -12.5% |
| 2023 | 0.34x | CN¥401.86 Million | CN¥276.91 Million | CN¥1.19 Billion | ▲ +26.7% |
| 2022 | 0.27x | CN¥253.57 Million | CN¥184.75 Million | CN¥949.93 Million | ▼ -43.0% |
| 2021 | 0.47x | CN¥284.97 Million | CN¥197.65 Million | CN¥608.64 Million | ▼ -9.0% |
| 2020 | 0.51x | CN¥289.58 Million | CN¥198.61 Million | CN¥562.78 Million | ▼ -34.4% |
| 2019 | 0.78x | CN¥289.08 Million | CN¥213.49 Million | CN¥368.51 Million | ▲ +94.1% |
| 2018 | 0.40x | CN¥201.78 Million | CN¥133.61 Million | CN¥499.27 Million | ▼ -16.7% |
| 2017 | 0.49x | CN¥248.56 Million | CN¥193.77 Million | CN¥512.41 Million | ▲ +16.0% |
| 2016 | 0.42x | CN¥167.56 Million | CN¥141.74 Million | CN¥400.56 Million | ▲ +29.0% |
| 2015 | 0.32x | CN¥173.69 Million | CN¥138.59 Million | CN¥535.63 Million | ▲ +68.6% |
| 2014 | 0.19x | CN¥98.93 Million | CN¥50.46 Million | CN¥514.36 Million | — |